Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Structure of Telomerase Deciphered, May Lead to Targeted Cancer Therapy
Link ID 8377
Title Structure of Telomerase Deciphered, May Lead to Targeted Cancer Therapy
Url http://www.medscape.com/viewarticle/579990?src=rss
Description Identification of the active region of telomerase, an enzyme that plays a major role in the development and progression of nearly all human malignancies, might eventually lead to new targeted therapies. Medscape Medical News
Category Articles > Hematology-Oncology
Keywords
Date Sep 4, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Hematology-Oncology
1. 6th European Breast Cancer Conference (EBCC)
  Read clinically focused news coverage of key developments from the meeting. Medscape Hematology-Oncology
Category:   Articles > Hematology-Oncology


2. Vitamin E and Selenium Do Not Prevent Prostate Cancer; Use of the Supplements Stopped in Large-Scale
  A National Cancer Institute-funded large-scale trial of 2 nutritional supplements shows no prostate cancer prevention benefit. Medscape Medical News
Category:   Articles > Hematology-Oncology


3. New Advances in the Treatment of Chronic Myelogenous Leukemia
  Review the development of imatinib resistance and management strategies for CML patients who develop resistance.
Category:   Articles > Hematology-Oncology


4. State Smoking Restrictions for Private-Sector Worksites, Restaurants, and Bars -- United States, 200
  Smoke-free indoor public places and worksites legislation in all 50 states and the District of Columbia is a Healthy People 2010 objective. What is our progress towards meeting this goal?
Morbidity & Mortality Weekly Report
Category:   Articles > Hematology-Oncology


5. Evolving Role of mTOR Inhibition in the Treatment of Renal Cell Carcinoma: An Expert Interview With
  In this Expert Interview from ASCO 2008, Dr. Robert Motzer discusses the evolving role of mTOR inhibition in the treatment of renal cell carcinoma, with a focus on the newest agent in the class.
Medscape Hematology-Oncology
Category:   Articles > Hematology-Oncology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS